 |
424 Diseases |  |
807 Trials |
|
807 Trials |  |
14372 News |  |
| «12...217218219220221222223224225226227...235236» |
- Trial completion: CALGB-10001: Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Mar 5, 2014
P2, N=58, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed
- 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg.
New P2 trial, Metastases: BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial (clinicaltrials.gov) - Mar 4, 2014
P2, N=50, Not yet recruiting, Sponsor: howard safran
- sunitinib / Generic mfg.
Trial withdrawal, Combination therapy, Surgery, Metastases: Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery (clinicaltrials.gov) - Mar 2, 2014
P2, N=0, Withdrawn, Sponsor: Federation Francophone de Cancerologie Digestive
Active, not recruiting --> Completed Recruiting --> Withdrawn
- Trial suspension: First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis (clinicaltrials.gov) - Mar 2, 2014
P2, N=65, Suspended, Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting --> Withdrawn Recruiting --> Suspended
- sunitinib / Generic mfg.
Enrollment change, Combination therapy, Surgery, Metastases: Sunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by Surgery (clinicaltrials.gov) - Mar 2, 2014
P2, N=0, Withdrawn, Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting --> Suspended N=70 --> 0
- Avastin (bevacizumab) / Roche
Enrollment change, Metastases: G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Mar 2, 2014
P2, N=20, Completed, Sponsor: Federation Francophone de Cancerologie Digestive
N=70 --> 0 N=30 --> 20
- |||| 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
Enrollment open: FFCD 1201 DEBIRI: Intra-arterial Hepatic Beads Loaded With Irinotecan With Concomitant Chemotherapy With FOLFOX in Patients With Colorectal Cancer With Unresectable Liver Metastases: a Phase II Multicenter Study (clinicaltrials.gov) - Mar 2, 2014
P2, N=58, Recruiting, Sponsor: Federation Francophone de Cancerologie Digestive
N=30 --> 20 Not yet recruiting --> Recruiting
- ||| Avastin (bevacizumab) / Roche
Enrollment closed, Metastases: PRODIGE-20: 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Mar 2, 2014
P2, N=102, Active, not recruiting, Sponsor: Federation Francophone de Cancerologie Digestive
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Avastin (bevacizumab) / Roche
Enrollment closed, Combination therapy, Metastases: A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer Patients (clinicaltrials.gov) - Mar 2, 2014
P1, N=45, Active, not recruiting, Sponsor: University of Chicago
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- | Avastin (bevacizumab) / Roche
Enrollment closed, Metastases: PRODIGE 9: Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Mar 2, 2014
P3, N=492, Active, not recruiting, Sponsor: Federation Francophone de Cancerologie Digestive
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||| Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer (clinicaltrials.gov) - Mar 2, 2014
P2, N=97, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Avastin (bevacizumab) / Roche
Trial completion, Metastases: G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Mar 2, 2014
P2, N=20, Completed, Sponsor: Federation Francophone de Cancerologie Digestive
Active, not recruiting --> Completed Not yet recruiting --> Completed
- | 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
Trial completion, Surgery, Metastases: Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery (clinicaltrials.gov) - Mar 2, 2014
P3, N=282, Completed, Sponsor: Federation Francophone de Cancerologie Digestive
Not yet recruiting --> Completed Recruiting --> Completed
- ||||| vincristine / Generic mfg.
Enrollment change: AALL0433: Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 27, 2014
P3, N=275, Active, not recruiting, Sponsor: Children's Oncology Group
Recruiting --> Completed N=418 --> 275
- || Enrollment change: AALL02P2: Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes (clinicaltrials.gov) - Feb 27, 2014
P=N/A, N=168, Active, not recruiting, Sponsor: Children's Oncology Group
N=418 --> 275 N=257 --> 168
- ||||| vincristine / Generic mfg.
Enrollment closed: AALL0433: Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 27, 2014
P3, N=275, Active, not recruiting, Sponsor: Children's Oncology Group
N=257 --> 168 Suspended --> Active, not recruiting
- Erbitux (cetuximab) / Eli Lilly
Enrollment change, Metastases: FOCULM: FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 26, 2014
P2, N=106, Recruiting, Sponsor: Sun Yat-sen University
Suspended --> Active, not recruiting N=60 --> 106
- Trial withdrawal: Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI (clinicaltrials.gov) - Feb 25, 2014
P1, N=0, Withdrawn, Sponsor: UNC Lineberger Comprehensive Cancer Center
N=60 --> 106 Recruiting --> Withdrawn
- Enrollment change: Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI (clinicaltrials.gov) - Feb 25, 2014
P1, N=0, Withdrawn, Sponsor: UNC Lineberger Comprehensive Cancer Center
Recruiting --> Withdrawn N=26 --> 0
- Erbitux (cetuximab) / Eli Lilly
Enrollment open, Metastases: FOCULM: FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 25, 2014
P2, N=106, Recruiting, Sponsor: Sun Yat-sen University
N=26 --> 0 Not yet recruiting --> Recruiting
- |||| Recentin (cediranib) / AstraZeneca
Trial completion, Combination therapy, Metastases: A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX (clinicaltrials.gov) - Feb 25, 2014
P1/2, N=172, Completed, Sponsor: AstraZeneca
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Avastin (bevacizumab) / Roche
Trial completion, Metastases: Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer (clinicaltrials.gov) - Feb 25, 2014
P=N/A, N=33, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neutrexin (trimetrexate) / Pfizer
Trial completion: Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma (clinicaltrials.gov) - Feb 22, 2014
P1, N=18, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting --> Completed Recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=35, Completed, Sponsor: Dana-Farber Cancer Institute
Recruiting --> Completed No longer recruiting --> Completed
- | melphalan / Generic mfg.
Trial completion, Metastases: Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Recruiting --> Completed
- ||||||| Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: Trial Of Irinotecan In Combination With Three Methods Of Administration Of Fluoropyrimidine. (clinicaltrials.gov) - Feb 22, 2014
P3, N=547, Completed, Sponsor: Pfizer
Recruiting --> Completed Active, not recruiting --> Completed
- |||| 5-fluorouracil / Generic mfg.
Trial completion, Metastases: A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=58, Completed, Sponsor: OSI Pharmaceuticals
Active, not recruiting --> Completed No longer recruiting --> Completed
- | alvocidib (DSP-2033) / Sumitomo Pharma
Trial completion, Metastases: Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=46, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed Active, not recruiting --> Completed
- |||| 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., pemetrexed / Generic mfg.
Trial completion, Metastases: Pemetrexed Plus a Comparator Versus a Combination of 2 Comparators in First-Line Treatment of Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P2, N=120, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed No longer recruiting --> Completed
- ||||||| Trial completion, Combination therapy, Surgery: A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=1886, Completed, Sponsor: Hoffmann-La Roche
No longer recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: NO16966: A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=2035, Completed, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Metastases: Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Suspended --> Completed
- ||||||| Erbitux (cetuximab) / Eli Lilly
Trial completion, Metastases: Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=102, Completed, Sponsor: ImClone LLC
Suspended --> Completed No longer recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Combination therapy, Metastases: A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=24, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||||| vatalanib (PTK787) / Novartis, Bayer
Trial completion, Metastases: Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. (clinicaltrials.gov) - Feb 22, 2014
P3, N=1168, Completed, Sponsor: Novartis
No longer recruiting --> Completed No longer recruiting --> Completed
- | imatinib / Generic mfg.
Trial completion: AALL01P2: Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=126, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed No longer recruiting --> Completed
- | thiotepa / Generic mfg.
Trial completion: Methotrexate and Thiotepa in Treating Patients With Newly Diagnosed Primary CNS Lymphoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=0, Completed, Sponsor: New Approaches to Brain Tumor Therapy
No longer recruiting --> Completed Recruiting --> Completed
- | Trial completion, Combination therapy, Surgery, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery (clinicaltrials.gov) - Feb 22, 2014
P1, N=50, Completed, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Active, not recruiting --> Completed
- | alvocidib (DSP-2033) / Sumitomo Pharma
Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - Feb 22, 2014
P1, N=77, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg.
Trial completion, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P=N/A, N=0, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | Trial completion, Combination therapy, Metastases: ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P1, N=22, Completed, Sponsor: National Cancer Institute (NCI)
No longer recruiting --> Completed No longer recruiting --> Completed
- 5-fluorouracil / Generic mfg., leucovorin calcium / Generic mfg., irinotecan / Generic mfg.
Trial completion, Combination therapy, Surgery: Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer (clinicaltrials.gov) - Feb 22, 2014
P3, N=0, Completed, Sponsor: Pfizer
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Avastin (bevacizumab) / Roche
Trial completion, Metastases: Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated (clinicaltrials.gov) - Feb 22, 2014
P3, N=880, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Herceptin (trastuzumab) / Roche
Trial completion: Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma (clinicaltrials.gov) - Feb 22, 2014
P2, N=80, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Metastases: Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) (clinicaltrials.gov) - Feb 22, 2014
P3, N=0, Completed, Sponsor: American College of Radiology Imaging Network
No longer recruiting --> Completed Not yet recruiting --> Completed
- ||| Alymsys (bevacizumab-maly) - Amneal, Pharmaceutical Libbs, Grupo Insud, Nichi / Iko, Stada
New P1 trial: Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN (clinicaltrials.gov) - Feb 20, 2014
P1, N=100, Not yet recruiting, Sponsor: mAbxience S.A
- pegvorhyaluronidase alfa (PEGPH20) / Halozyme
Enrollment open, Metastases: S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer (clinicaltrials.gov) - Feb 20, 2014
P1/2, N=172, Recruiting, Sponsor: Southwest Oncology Group
Not yet recruiting --> Completed Not yet recruiting --> Recruiting
- | alvocidib (DSP-2033) / Sumitomo Pharma
Trial completion, Combination therapy, Metastases: Combination Chemotherapy in Treating Patients With Advanced Cancer (clinicaltrials.gov) - Feb 19, 2014
P1, N=90, Completed, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting No longer recruiting --> Completed
- | Erbitux (cetuximab) / Eli Lilly
Trial completion, Combination therapy, Metastases: Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
No longer recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Metastases: Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed No longer recruiting --> Completed